Variant report
Variant | esv3426659 |
---|---|
Chromosome Location | chr5:44494020-44496957 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:44495531..44496060-chr5:44774142..44775059,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FGF10-1 | chr5:44495720-44495895 | ENSG00000249203 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146321143 | chr5:44494608-44494609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs386687752 | chr5:44494651-44494652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10941667 | chr5:44494681-44494682 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs548638928 | chr5:44494715-44494716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545857551 | chr5:44494733-44494734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139726292 | chr5:44494758-44494759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34996429 | chr5:44494771-44494772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560211768 | chr5:44494777-44494778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149020439 | chr5:44495720-44495721 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs549909252 | chr5:44495765-44495766 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs563432770 | chr5:44495786-44495787 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs548946231 | chr5:44496003-44496004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531578562 | chr5:44496030-44496031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147707719 | chr5:44496031-44496032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535025669 | chr5:44496067-44496068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71584718 | chr5:44496112-44496113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1384453 | chr5:44496114-44496115 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs537646866 | chr5:44496124-44496125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535384023 | chr5:44496140-44496141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556332765 | chr5:44496159-44496160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576188674 | chr5:44496172-44496173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535470519 | chr5:44496193-44496194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185132850 | chr5:44496216-44496217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111625832 | chr5:44496221-44496222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368566296 | chr5:44496261-44496262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147797379 | chr5:44496294-44496295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564403844 | chr5:44496304-44496305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368562802 | chr5:44496327-44496328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371937910 | chr5:44496379-44496380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577802749 | chr5:44496414-44496415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2062140 | chr5:44496415-44496416 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs187979780 | chr5:44496422-44496423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529370011 | chr5:44496483-44496484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539429578 | chr5:44496484-44496485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75733505 | chr5:44496485-44496486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369761770 | chr5:44496497-44496498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73752036 | chr5:44496500-44496501 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs146979632 | chr5:44496594-44496595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111381284 | chr5:44496612-44496613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148025241 | chr5:44496613-44496614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569254154 | chr5:44496624-44496625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116305035 | chr5:44496627-44496628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551172507 | chr5:44496652-44496653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200265143 | chr5:44496659-44496660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs5867669 | chr5:44496660-44496661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397738134 | chr5:44496661-44496662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181201360 | chr5:44496729-44496730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112021364 | chr5:44496815-44496816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572294066 | chr5:44496831-44496832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs543856875 | chr5:44496882-44496883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:44494600-44494800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr5:44496000-44499800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:44496600-44496800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr5:44496800-44509000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |